Bret A Connors1, Tony Gardner1, Ziyue Liu2, James E Lingeman3, James C Williams1. 1. Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA. 2. Department of Biostatistics, and Indiana University School of Medicine, Indianapolis, Indiana, USA. 3. Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Abstract
Purpose: Pretreating the kidney with 100 low-energy shock waves (SWs) with a time pause before delivering a clinical dose of SWs (Dornier HM-3, 2000 SWs, 24 kV, and 120 SWs/min) has been shown to significantly reduce the size of the hemorrhagic lesion produced in that treated kidney, compared to a protocol without pretreatment. It has been assumed that a similar reduction in injury will occur with lithotripters other than the HM-3, but experiments to confirm this assumption are lacking. In this study, we sought to verify that the lesion protection phenomenon also occurs in a lithotripter using an electromagnetic shock source and dry-head coupling. Materials and Methods: Eleven female pigs were placed in a Dornier Compact S lithotripter where the left kidney of each animal was targeted for lithotripsy treatment. Some kidneys received 2500 SWs at power level (PL) = 5 (120 SWs/min) while some kidneys were pretreated with 100 SWs at PL = 1, with a 3-minute time pause, followed immediately by 2500 SWs at PL = 5 (120 SWs/min). Lesion size analysis was performed to assess the volume of hemorrhagic tissue injury created by each treatment regimen (% functional renal volume). Results: Lesion size fell by 85% (p = 0.01) in the 100 SW pretreatment group compared to the injury produced by a regimen without pretreatment. Conclusions: The results suggest that the treatment pause protection phenomenon occurs with a Dornier Compact S, a machine distinctly different from the Dornier HM-3. This result also suggests that this phenomenon may be observed generally in SW lithotripters.
Purpose: Pretreating the kidney with 100 low-energy shock waves (SWs) with a time pause before delivering a clinical dose of SWs (Dornier HM-3, 2000 SWs, 24 kV, and 120 SWs/min) has been shown to significantly reduce the size of the hemorrhagic lesion produced in that treated kidney, compared to a protocol without pretreatment. It has been assumed that a similar reduction in injury will occur with lithotripters other than the HM-3, but experiments to confirm this assumption are lacking. In this study, we sought to verify that the lesion protection phenomenon also occurs in a lithotripter using an electromagnetic shock source and dry-head coupling. Materials and Methods: Eleven female pigs were placed in a Dornier Compact S lithotripter where the left kidney of each animal was targeted for lithotripsy treatment. Some kidneys received 2500 SWs at power level (PL) = 5 (120 SWs/min) while some kidneys were pretreated with 100 SWs at PL = 1, with a 3-minute time pause, followed immediately by 2500 SWs at PL = 5 (120 SWs/min). Lesion size analysis was performed to assess the volume of hemorrhagic tissue injury created by each treatment regimen (% functional renal volume). Results: Lesion size fell by 85% (p = 0.01) in the 100 SW pretreatment group compared to the injury produced by a regimen without pretreatment. Conclusions: The results suggest that the treatment pause protection phenomenon occurs with a Dornier Compact S, a machine distinctly different from the Dornier HM-3. This result also suggests that this phenomenon may be observed generally in SW lithotripters.
Authors: Bret A Connors; Andrew P Evan; Philip M Blomgren; Lynn R Willis; Rajash K Handa; David A Lifshitz; James E Lingeman; Jun Ying Journal: J Endourol Date: 2006-09 Impact factor: 2.942
Authors: Rajash K Handa; James A McAteer; Bret A Connors; Ziyue Liu; James E Lingeman; Andrew P Evan Journal: BJU Int Date: 2012-05-22 Impact factor: 5.588
Authors: Bret A Connors; Andrew P Evan; Rajash K Handa; Philip M Blomgren; Cynthia D Johnson; Ziyue Liu; James E Lingeman Journal: J Endourol Date: 2016-07-13 Impact factor: 2.942
Authors: Bret A Connors; Andrew P Evan; Lynn R Willis; Philip M Blomgren; James E Lingeman; Naomi S Fineberg Journal: J Am Soc Nephrol Date: 2000-02 Impact factor: 10.121
Authors: Bret A Connors; Andrew P Evan; Philip M Blomgren; Rajash K Handa; Lynn R Willis; Sujuan Gao Journal: BJU Int Date: 2008-08-01 Impact factor: 5.588
Authors: Franklin C Lee; Ryan S Hsi; Mathew D Sorensen; Marla Paun; Barbrina Dunmire; Ziyue Liu; Michael Bailey; Jonathan D Harper Journal: J Endourol Date: 2015-10-26 Impact factor: 2.942
Authors: Youzhi Shao; Bret A Connors; Andrew P Evan; Lynn R Willis; David A Lifshitz; James E Lingeman Journal: Anat Rec A Discov Mol Cell Evol Biol Date: 2003-11
Authors: Bret A Connors; Andrew P Evan; Philip M Blomgren; Rajash K Handa; Lynn R Willis; Sujuan Gao; James A McAteer; James E Lingeman Journal: BJU Int Date: 2009-03-26 Impact factor: 5.588